| Literature DB >> 28426695 |
Sang Hoon Song1, Chanwoo Lee1, Jaeyoon Jung1, Sung Jin Kim1, Sungchan Park2, Hyungkeun Park1, Kun Suk Kim1.
Abstract
PURPOSE: To compare the outcomes of open pyeloplasty (OP), laparoscopy-assisted extracorporeal (LEXP), and robotic-assisted laparoscopic pyeloplasty (RALP) for ureteropelvic junction obstruction in pediatric patients.Entities:
Mesh:
Year: 2017 PMID: 28426695 PMCID: PMC5398516 DOI: 10.1371/journal.pone.0175026
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient demographics according to the surgical method used.
| Group 1 | Group 2 | Group 3 | P-value | |
|---|---|---|---|---|
| Age at surgery, med (range), (years) | 8.5 (2–19) | 10.5 (2–16) | 11.0 (4–18) | 0.175 |
| Height at surgery, med (range), (cm) | 131.1 (87.9–181.3) | 146.0 (88.7–180.0) | 148.6 (106.3–183.1) | 0.083 |
| Weight at surgery, med (range), (cm) (kg) | 27.0 (11.2–93.6) | 39.5 (13.4–75.0) | 40.1 (14.5–92.8) | 0.240 |
| BMI at surgery, med (range) (kg/m2) | 16.7 (13.9–28.4) | 17.6 (13.1–23.1) | 17.8 (12.8–28.2) | 0.810 |
| Gender (Male: Female) | 22:8 (73.3:26.7) | 20:10 (66.7:33.3) | 8:2(80.0:20.0) | 0.819 |
| Laterality (Right: Left) | 8:22 (26.7:73.3) | 6:24 (20.0:80.0) | 3:7 (30.0:71.0) | 0.647 |
| s-Creatinine at surgery, med (range), (mg/dl) | 0.6 (0.3–1.0) | 0.6 (0.4–1.4) | 0.6 (0.4–1.4) | 0.315 |
| SFU grade at surgery, med (range) | 4.0 (2–5) | 3.0 (2–5) | 4.0 (3–4) | 0.066 |
| APPD at surgery, med (range), (cm) | 2.8 (1.2–5.8) | 3.6 (0.7–7.9) | 2.2 (1.2–5.5) | 0.488 |
| Split renal function at surgery, med (range), (%) | 45.9 (13.4–100) | 47.4 (23.3–72.0) | 43.3 (11.2–52.1) | 0.290 |
| No. presentation (%) | 0.438 | |||
| • Prenatally detected | 5 (16.7) | 4 (13.3) | 0 (0) | |
| • Flank pain | 18 (60.0) | 18 (60.0) | 9 (90.0) | |
| • Incidentally detected | 3 (0.0) | 3 (10.0) | 0 (0) | |
| • Abdominal mass | 0 (0) | 1 (3.3) | 0 (0) | |
| • Gross hematuria | 1 (3.3) | 4 (13.3) | 1 (10.0) | |
| • UTI | 3 (10.0) | 0 (0) | 0 (0) |
SD = standard deviation; OP = open pyeloplasty; LEXP = laparoscopy-assisted extracorporeal pyeloplasty; RALP = robot-assisted laparoscopic pyeloplasty; BMI = body mass index; s-creatinine = serum creatinine; SFU = society of fetal urology; APPD = anteroposterior pelvic diameter; UTI = urinary tract infection;
a = Krusak-Wallis test
Peri- and post-operative outcomes according to the surgical technique.
| Group 1 | Group 2 | Group 3 | ||
|---|---|---|---|---|
| Etiology | 0.622 | |||
| • Intrinsic-primary | 25 (83.3) | 21 (70.0) | 5 (50.0) | |
| • Intrinsic-polyp | 2 (6.6) | 2 (6.7) | 0 (0) | |
| • Extrinsic (crossing vessel) | 3 (10.0) | 7 (23.3) | 5 (50.0) | |
| No. transmesenteric approach (%) | 0 (0) | 0 (0) | 6 (60.0) | < 0.001 |
| Mean ± SD operation time (mins) | 192.5 ± 67.1 | 197.4 ± 38.9 | 254.1 ± 46.0 | 0.008 |
| No. stent insertion (%) | 10 (33.3%) | 22 (73.3%) | 8 (80%) | < 0.001 |
| Mean ± SD Foley duration (days) | 3.4 ± 0.8 | 3.1 ± 0.9 | 1.7 ± 0.8 | < 0.001 |
| Mean ± SD LOS (days) | 6.6 ± 1.5 | 5.8 ± 1.4 | 3.2 ± 1.0 | < 0.001 |
| Mean ± SD analgesic usage duration (days) | 3.2 ± 1.0 | 2.4 ± 1.3 | 1.1 ±1.2 | < 0.001 |
| Complications | 4 (13.3) | 4 (13.3) | 1 (10.0) | 0.664 |
| • Intraoperative | 0 (0) | 0 (0) | 1 (10.0) | |
| • Immediate | ||||
| 1. Ileus | 0 (0) | 1 (3.3) | 0 (0) | |
| 2. Wound dehiscence | 1 (3.3) | 0 (0) | 0 (0) | |
| 3. UPJ obstruction | 1 (3.3) | 2 (6.6) | 0 (0) | |
| • Late | ||||
| 1. Nonfunctioning kidney | 0 (0) | 0 (0) | 0 (0) | |
| 2. UTI | 2 (6.6) | 1 (3.3) | 0 (0) | |
| Mean ± SD FU duration (months) | 49.0 ± 31.8 | 20.1 ± 15.1 | 16.6 ± 10.3 | < 0.001 |
| No. postop hydronephrosis SFU grade (%) | 0.406 | |||
| • Grade 0 | 1 (3.3) | 3 (10.0) | 2 (20.0) | |
| • Grade 1 | 9 (30.0) | 8 (26.7) | 3 (30.0) | |
| • Grade 2 | 12 (40.0) | 11 (36.7) | 1 (10.0) | |
| • Grade 3 | 7 (23.3) | 7 (23.3) | 4 (40.0) | |
| • Grade 4 | 1 (3.3) | 1 (3.3) | 0 (0.0) | |
| Mean ± SD postop APPD (cm) | 1.5 ± 0.9 | 1.3 ± 1.0 | 1.3 ± 0.6 | 0.667 |
| • % reduction from preop APPD | 52.4 ± 31.4 | 43.2 ± 35.5 | 47.6 ± 24.5 | 0.577 |
| Mean ± SD postop split renal function (%) | 45.9 ± 10.9 | 47.2 ± 10.4 | 34.1 ± 18.0 | 0.031 |
| • Change from preop function | 1.9 ± 4.6 | 2.6 ± 3.7 | 3.0 ± 5.7 | 0.746 |
| Mean ± SD postop T1/2 on MAG3 renal scan | 6.9 ± 3.7 | 7.8 ± 4.5 | 6.8 ± 3.4 | 0.409 |
SD = standard deviation; OP = open pyeloplasty; LEXP = laparoscopy-assisted extracorporeal pyeloplasty; RALP = robot-assisted laparoscopic pyeloplasty; LOS = length of stay; UTI = urinary tract infection; FU = follow up; postop = postoperative; preop = preoperative; APPD = anteroposterior pelvic diameter;
a Postoperative hydronephrosis grade and APPD were data collected at the last visit to the clinic
Logistic regression analysis for the prediction of success.
| Univariate | Multivariate | ||||
|---|---|---|---|---|---|
| OR | OR | 95% CI | |||
| Gender | 0.362 | 328 | 2.671 | 0.169–42.240 | 0.485 |
| Age at op | 1.137 | 0.310 | 1.018 | 0.989–1.048 | 0.233 |
| Op method | |||||
| Preop HN grade | 1.395 | 0.622 | |||
| Preop APPD | 1.285 | 0.561 | |||
| Preop split renal function | 0.979 | 0.523 | |||
| Dismember or not | 0.148 | 0.140 | |||
| Preop stone | 1.134 | 0.999 | |||
| Preop UTI | 0.254 | 0.271 | |||
| Preop GHU | 1.095 | 0.999 | |||
| Preop PCN | 1.584 | 0.999 | |||
| Crossing vessel | 0.077 | 0.032 | 0.077 | 0.007–0.805 | 0.032 |
| Stent insertion | 0.487 | 0.543 | 0.813 | 0.021–31.834 | 0.912 |
| PCN insertion | 1.095 | 0.999 | |||
OP = open pyeloplasty; LEXP = laparoscopy-assisted extracorporeal pyeloplasty; RALP = robot-assisted laparoscopic pyeloplasty; HN = hydronphrosis; APPD = anteroposterior pelvic diameter; UTI = urinary tract infection; GHU = gross hematuria; PCN = percutaneous nephrostomy
Fig 1Cosmetic outcome.
Cosmetic outcome after robot assisted laparoscopic pyeloplasty (RALP) was superior than that for laparoscopy-assisted extracorporeal pyeloplasty (LEXP) and open pyeloplasty (OP). For RALP, port-site scars were seen 1 month after operation (A) and became much fainter 1 year after the operation (B). The size of the abdominal scar was shorter with LEXP (C) than with OP (D), although an additional port-site scar was seen in the left lower quadrant in patients who underwent LEXP (C).
Fig 2Learning curve of robot assisted laparoscopic pyeloplasty.
Linear graph of perioperative time, console time, and anastomosis time as a function of increasing surgical experience. The total operation time showed a tendency to decrease with the surgeon’s experience with robot assisted laparoscopic pyeloplasty cases (P = 0.061).